1. Home
  2. LIXT vs NTZ Comparison

LIXT vs NTZ Comparison

Compare LIXT & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.99

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Logo Natuzzi S.p.A.

NTZ

Natuzzi S.p.A.

N/A

Current Price

$2.17

Market Cap

29.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
LIXT
NTZ
Founded
2005
1959
Country
United States
Italy
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
29.4M
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
LIXT
NTZ
Price
$3.99
$2.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
90.8K
4.1K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$359,714,621.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$2.15
52 Week High
$6.26
$6.27

Technical Indicators

Market Signals
Indicator
LIXT
NTZ
Relative Strength Index (RSI) 42.98 41.48
Support Level $4.01 $2.17
Resistance Level $4.40 $2.58
Average True Range (ATR) 0.31 0.22
MACD -0.01 -0.01
Stochastic Oscillator 22.34 26.16

Price Performance

Historical Comparison
LIXT
NTZ

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: